ArticleClinical & translational immunology2024

Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised mice.

Chloe Sligar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.